Savara Inc. (SVRA)
NASDAQ·Healthcare·Biotechnology
$5.45
+2.25%
Mkt Cap $1.14B
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+83.5%
Consensus $10.00 vs current $5.45
NASDAQ·Healthcare·Biotechnology
$5.45
+2.25%
Mkt Cap $1.14B
No recent rating data.
Price Target (11 analysts)
$10.00
Range $10.00 – $10.00
+83.5%
Consensus $10.00 vs current $5.45